<DOC>
	<DOCNO>NCT02241395</DOCNO>
	<brief_summary>The purpose study study effect autologous bone marrow mononuclear cell common symptom cerebral palsy patient .</brief_summary>
	<brief_title>Cell Therapy Treatment Cerebral Palsy</brief_title>
	<detailed_description />
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<criteria>diagnose case type Cerebral Palsy age 6 month . presence acute infection Human immunodeficiency virus/Hepatitis B Virus/ Hepatitis C Virus malignancy bleed tendency pneumonia renal failure severe liver dysfunction severe anemia [ Hemoglobin &lt; 8 ] bone marrow disorder space occupy lesion brain acute medical condition respiratory infection pyrexia .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Cerebral Palsy</keyword>
	<keyword>autologous bone marrow mononuclear cell</keyword>
	<keyword>stem cell</keyword>
</DOC>